Stocks
Medtronic Financial Statements (MDT) |
||||||||||
| Medtronicsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.06.2021 | 29.04.2022 | 23.06.2022 | 30.04.2023 | 22.06.2023 | 27.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 30 117 | 31 686 | 31 686 | 31 227 | 31 227 | 24 057 | |||
| Operating Income, bln rub | 4 484 | 5 752 | 5 752 | 5 485 | 5 485 | 4 163 | ||||
| EBITDA, bln rub | ? | 7 933 | 8 755 | 8 932 | 9 042 | 9 042 | 6 023 | |||
| Net profit, bln rub | ? | 3 606 | 5 039 | 5 039 | 3 758 | 3 758 | 3 140 | |||
| OCF, bln rub | ? | 6 240 | 7 346 | 7 346 | 6 039 | 6 039 | 3 807 | |||
| CAPEX, bln rub | ? | 1 355 | 1 368 | 1 368 | 1 459 | 1 459 | 1 268 | |||
| FCF, bln rub | ? | 4 885 | 5 978 | 5 978 | 4 580 | 4 580 | 2 539 | |||
| Dividend payout, bln rub | 3 120 | 3 383 | 3 383 | 3 616 | 3 616 | 2 753 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| Dividend payout ratio, % | 86.5% | 67.1% | 67.1% | 96.2% | 96.2% | 87.7% | ||||
| OPEX, bln rub | 14 739 | 13 038 | 15 633 | 14 678 | 14 678 | 10 924 | ||||
| Cost of production, bln rub | 10 483 | 10 145 | 10 145 | 10 719 | 10 719 | 8 304 | ||||
| R&D, bln rub | 2 493 | 2 746 | 2 746 | 2 696 | 2 696 | 2 091 | ||||
| Interest expenses, bln rub | 925.0 | 553.0 | 553.0 | 636.0 | 636.0 | 548.0 | ||||
| Assets, bln rub | 93 083 | 90 981 | 90 981 | 90 948 | 90 948 | 90 836 | ||||
| Net Assets, bln rub | ? | 51 428 | 52 551 | 52 551 | 51 483 | 51 483 | 51 792 | |||
| Debt, bln rub | 26 389 | 24 114 | 24 114 | 24 364 | 24 364 | 25 182 | ||||
| Cash, bln rub | 10 817 | 10 573 | 10 573 | 7 959 | 7 959 | 8 321 | ||||
| Net debt, bln rub | 15 572 | 13 541 | 13 541 | 16 405 | 16 405 | 16 861 | ||||
| Ordinary share price, rub | 130.9 | 104.4 | 104.4 | 91.0 | 91.0 | 72.0 | ||||
| Number of ordinary shares, mln | 1 345 | 1 342 | 1 342 | 1 330 | 1 330 | 1 330 | ||||
| Market cap, bln rub | 176 074 | 140 093 | 140 093 | 120 945 | 120 945 | 95 738 | ||||
| EV, bln rub | ? | 191 646 | 153 634 | 153 634 | 137 350 | 137 350 | 112 599 | |||
| Book value, bln rub | -8 273 | -3 546 | -3 546 | -4 786 | -4 786 | -3 058 | ||||
| EPS, rub | ? | 2.68 | 3.75 | 3.75 | 2.83 | 2.83 | 2.36 | |||
| FCF/share, rub | 3.63 | 4.45 | 4.45 | 3.44 | 3.44 | 1.91 | ||||
| BV/share, rub | -6.15 | -2.64 | -2.64 | -3.60 | -3.60 | -2.30 | ||||
| EBITDA margin, % | ? | 26.3% | 27.6% | 28.2% | 29.0% | 29.0% | 25.0% | |||
| Net margin, % | ? | 12.0% | 15.9% | 15.9% | 12.0% | 12.0% | 13.1% | |||
| FCF yield, % | ? | 2.77% | 4.27% | 4.27% | 3.79% | 3.79% | 2.65% | |||
| ROE, % | ? | 7.01% | 9.59% | 9.59% | 7.30% | 7.30% | 6.06% | |||
| ROA, % | ? | 3.87% | 5.54% | 5.54% | 4.13% | 4.13% | 3.46% | |||
| P/E | ? | 48.8 | 27.8 | 27.8 | 32.2 | 32.2 | 30.5 | |||
| P/FCF | 36.0 | 23.4 | 23.4 | 26.4 | 26.4 | 37.7 | ||||
| P/S | ? | 5.85 | 4.42 | 4.42 | 3.87 | 3.87 | 3.98 | |||
| P/BV | ? | -21.3 | -39.5 | -39.5 | -25.3 | -25.3 | -31.3 | |||
| EV/EBITDA | ? | 24.2 | 17.5 | 17.2 | 15.2 | 15.2 | 18.7 | |||
| Debt/EBITDA | 1.96 | 1.55 | 1.52 | 1.81 | 1.81 | 2.80 | ||||
| R&D/CAPEX, % | 184.0% | 200.7% | 200.7% | 184.8% | 184.8% | 164.9% | ||||
| CAPEX/Revenue, % | 4.50% | 4.32% | 4.32% | 4.67% | 4.67% | 5.27% | ||||
| Medtronic shareholders | ||||||||||
